Hasten Biopharmaceutic (Switzerland) AG - Hanarbe 40 mg, Tabletten | | 69936 | | 02 | | Hanarbe 40 mg | | Tabletten | | C09CA09 | | Azilsartan Medoxomil | | 08.08.2024 | | |
| Composition | azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg. | Packungsbestandteile | | Tablets | | Active Agent | Dose |
---|
Azilsartanum Medoxomilum | 40 mg |
| | Inactive agents | Dose |
---|
Acidum Fumaricum | | Carmellosum Natricum Conexum | | Cellulosum Microcristallinum | | Hydroxypropylcellulosum | | Magnesii Stearas | | Mannitol | | Sodium Hydroxide | | Sodium | 1.6 mg | Pro Compresso | |
|
| |
|